Status:
UNKNOWN
rTMS on Appetite and Cognitive Function in Schizophrenia
Lead Sponsor:
Central South University
Collaborating Sponsors:
Shanghai Mental Health Center
Conditions:
Schizophrenia
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The weight gain and metabolic dysfunction has been vital conditions for individuals with schizophrenia. rTMS is a promising novel intervention, which have strong potentials on moderating increased app...
Detailed Description
The weight gain and metabolic dysfunction has been vital conditions for individuals with schizophrenia. The cognitive function deficit has also been a major symptom for schizophrenia. However, metabol...
Eligibility Criteria
Inclusion
- Patients with schizophrenia in accordance with DSM-5
- Commorbid with significant weight gain after antipsychotics
- Informed Consent
Exclusion
- Diagnosed with other mental disease in accordance with DSM-5
- Comorbid with other severe physiological disease
- Used antipsychotic, antidepressants, mood stabilizer, or other psychoactive substances before
- Drug or alcohol abuse
- Pregnant or lactating
- Contraindication to rTMS
Key Trial Info
Start Date :
April 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04714970
Start Date
April 20 2021
End Date
December 1 2022
Last Update
November 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central South University
Changsha, Hunan, China, 410000